Marshall Wace, LLP Neogenomics Inc Transaction History

Marshall Wace, LLP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $285,767 - $565,463	40,477 New	40,477 $330,000
Q1 2022 May 16, 2022	SELL	$12.15 - $35.28 $535,353 - $1.55 Million	-44,062 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$30.49 - $48.49 $1.34 Million - $2.14 Million	44,062 New	44,062 $1.5 Million
Q2 2021 Aug 13, 2021	SELL	$36.62 - $51.69 $155,927 - $220,096	-4,258 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$41.56 - $59.88 $176,962 - $254,969	4,258 New	4,258 $205,000
Q1 2020 May 15, 2020	SELL	$20.5 - $34.53 $629,493 - $1.06 Million	-30,707 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$18.96 - $29.84 $5.65 Million - $8.9 Million	-298,162 Reduced 90.66%	30,707 $898,000
Q3 2019 Nov 14, 2019	SELL	$19.12 - $26.24 $19.7 Million - $27 Million	-1,029,444 Reduced 75.79%	328,869 $6.29 Million
Q2 2019 Aug 14, 2019	BUY	$19.57 - $24.1 $22.1 Million - $27.2 Million	1,129,043 Added 492.45%	1,358,313 $29.8 Million
Q1 2019 May 14, 2019	SELL	$12.14 - $20.46 $7.81 Million - $13.2 Million	-643,025 Reduced 73.72%	229,270 $4.69 Million
Q4 2018 Feb 14, 2019	BUY	$11.24 - $18.5 $9.8 Million - $16.1 Million	872,295 New	872,295 $11 Million
Q2 2018 Aug 14, 2018	SELL	$7.99 - $14.05 $440,249 - $774,155	-55,100 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$7.23 - $8.76 $398,373 - $482,676	55,100 New	55,100 $450,000

293

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.8B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.